“My foot is swollen like a steamed bun, the pain is unbearable — why is it so severe?”

“My uric acid is normal, so I can rule out gout, right?”

“Why do I still have gout attacks even when I take my meds properly? Is there any point in treating it?”

Gout cases are rising, and such questions are common in rheumatology clinics. Patients suffer intensely during flare‑ups, yet few stick to medication once the acute phase passes. Let’s clarify key facts about gout.

What Is the Link Between Hyperuricemia and Gout?

Hyperuricemia is a metabolic disorder from purine imbalance: under normal diet, fasting serum uric acid > 420 μmol/L on two separate days. Above this saturation level, uric acid crystals form and deposit in joints, triggering gout. Most gout patients have hyperuricemia.

• Prevalence in Chinese adults: 14% hyperuricemia, 3.2% gout, rising yearly.

• Acute gout: sudden severe joint redness, swelling, heat, pain. Recurrent attacks cause irreversible joint damage and raise risks of kidney, cardiovascular, and endocrine diseases.

6 Common Myths About Gout

Myth 1: Gout gets better on its own — no meds needed

Why the myth: Acute gout is self‑limiting; pain/swelling eases in days without urate‑lowering drugs. People think it’s mild and doesn’t need treatment.

Truth: Symptoms fade, but uric acid stays high. Untreated gout leads to recurrent attacks, tophi, joint destruction, and kidney damage.

Myth 2: Urate‑lowering drugs harm liver/kidneys — avoid them

Why the myth: Fear of side effects, “all drugs are toxic,” and claims of “side‑effect‑free” folk remedies.

Truth: Drugs are safe under medical supervision with regular liver/kidney checks. Most patients tolerate them well. Unverified folk remedies are far riskier for kidneys and disease control. The benefits of proper medication outweigh risks.

Myth 3: Normal uric acid = cured — stop meds

Why the myth: Normal lab results lead patients to think gout is cured and stop treatment, ignoring long‑term control.

Truth: Treatment aims for stable, long‑term uric acid control at target levels. Even if normal, do not stop abruptly — taper under medical supervision. Sudden discontinuation causes uric acid rebound and flare‑ups.

Myth 4: Diet control alone lowers uric acid — no meds needed

Why the myth: Gout is seen as “diet‑caused.” Cut seafood/alcohol, and uric acid drops.

Truth: Only 20% of uric acid comes from diet; 80% from internal metabolism. Diet alone rarely hits targets (<360 μmol/L) for most patients. Diet + medication is the scientific approach.

Myth 5: Take meds only during attacks — ignore when pain‑free

Why the myth: Patients remember pain, relax when symptoms fade, and think “no pain = no disease.”

Truth: Gout is chronic metabolic disease — pain‑free ≠ controlled uric acid. High uric acid damages joints and kidneys long‑term. Start/continue urate‑lowering therapy 2 weeks after acute flare resolution, not just during pain.

Myth 6: Gout is a “men’s disease” — women don’t get it

Why the myth: Gout is more common in older men, so women are thought to be immune.

Truth: Women also get gout, especially postmenopausal women. Ignorance delays diagnosis and treatment.

How Is Gout Treated?

Hyperuricemia and gout require active monitoring and intervention. Personalized plans are key, combining non‑drug and drug therapy.

Non‑drug interventions (foundational):

• Maintain healthy weight, exercise regularly, strictly limit alcohol.

• Avoid high‑purine foods: organ meats, high‑fructose drinks/sodas.

• Limit red meat (beef/lamb/pork), high‑purine seafood (sardines, shellfish).

Acute Gout: Fast‑acting Medications

Acute flares cause sudden severe pain, disrupting daily life. While self‑resolving in 1–2 weeks, anti‑inflammatory treatment speeds recovery.

• NSAIDs: Diclofenac, celecoxib, etoricoxib. Caution: avoid with GI bleeding or renal impairment.

• Colchicine: Best within 12 hours. Dose: 1.0 mg initially → 0.5 mg after 1 hour → 1–1.5 mg daily after 12 hours. Stop if diarrhea occurs.

• Corticosteroids: Short‑term anti‑inflammatory use (not long‑term).

• Alternative: IL‑1 inhibitors (e.g., canakinumab, anakinra) for patients intolerant to above drugs or with severe GI/renal issues.

Post‑acute Phase: Urate‑Lowering Medications

Start under medical guidance. Common options:

1. Uricosurics: Benzbromarone, dotinurad

2. Xanthine oxidase inhibitors: Allopurinol, febuxostat

   (Sodium bicarbonate alkalizes urine as adjunct; it does not lower uric acid alone.)

Important: Seek professional care for standardized gout treatment. Always follow your doctor’s prescription.